Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04854421 · ClinicalTrials.gov registry record
Evaluation of the Accuracy of a Computer Vision-based Tool for Assessment of Total Body Fat Percentage
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 138
- Enrollment target
NCT04854421: Completed study, sponsored by Pennington Biomedical Research Center.
NCT04854421 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04854421 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
This research study is designed to validate the precision and accuracy of body measurement and composition results from a novel 2D imaging device that operates through a smart-phone application. Measurement references will be obtained through dual energy x-ray absorptiometry, air displacement plethysmography, bioelectrical impedance analysis, manual anthropometry, and previously validated 3D optical scanners.
Primary Outcome
Comparison of Body Fat Percentage estimates to DXA references classified by Body Mass Index
Interventions
- DEVICE VBC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2020-12-21 |
What the finished NCT04854421 record still lists
NCT04854421 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which VBC is the first listed.
NCT04854421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04854421 about?
NCT04854421 is a clinical study titled "Evaluation of the Accuracy of a Computer Vision-based Tool for Assessment of Total Body Fat Percentage". This research study is designed to validate the precision and accuracy of body measurement and composition results from a novel 2D imaging device that operates through a smart-phone application. Measurement references will be obtained through dual energy x-ray absorptiometry, air displacement plethy...
What is the current status of trial NCT04854421?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2020-08-12. Estimated completion is 2020-12-21.
What interventions are being tested in trial NCT04854421?
The interventions under investigation include: VBC (DEVICE).
Who is sponsoring clinical trial NCT04854421?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI